- call +1-201-465-4211
- email sales@mrinsights.biz
Rheumatoid arthritis (RA) is an inflammatory disease that progresses over time affecting the joints. The symptoms aggravate over time, which is why medication for RA becomes essential to stop the inflammation. There is no permanent cure for rheumatoid arthritis, though increasing research activities regarding the same indicate that remission of symptoms is achieved when treatment begins in the initial stages with strong medications known as disease-modifying antirheumatic drugs (DMARDs).
Scope of the Report:
This report studies the Rheumatoid Arthritis (RA) Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rheumatoid Arthritis (RA) Drugs market by product type and applications/end industries.
The global Rheumatoid Arthritis (RA) Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rheumatoid Arthritis (RA) Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
AbbVie
Roche
Johnson & Johnson
Amgen, Inc.
Pfizer
Merck
Bristol-Myers Squibb
UCB
GlaxoSmithKline
Sanofi
Abbott Laboratories
Teva Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Injection
External
Market Segment by Applications, can be divided into
Medical Care
Personal Care
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Rheumatoid Arthritis (RA) Drugs Market Overview
1.1 Product Overview and Scope of Rheumatoid Arthritis (RA) Drugs
1.2 Classification of Rheumatoid Arthritis (RA) Drugs by Types
1.2.1 Global Rheumatoid Arthritis (RA) Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Types in 2017
1.2.3 Oral
1.2.4 Injection
1.2.5 External
1.3 Global Rheumatoid Arthritis (RA) Drugs Market by Application
1.3.1 Global Rheumatoid Arthritis (RA) Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Rheumatoid Arthritis (RA) Drugs Market by Regions
1.4.1 Global Rheumatoid Arthritis (RA) Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Rheumatoid Arthritis (RA) Drugs (2013-2023)
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Amgen, Inc.
2.4.1 Business Overview
2.4.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
2.6.1 Business Overview
2.6.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol-Myers Squibb
2.7.1 Business Overview
2.7.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 UCB
2.8.1 Business Overview
2.8.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 UCB Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 GlaxoSmithKline
2.9.1 Business Overview
2.9.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.11 Abbott Laboratories
2.11.1 Business Overview
2.11.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.12 Teva Pharmaceutical
2.12.1 Business Overview
2.12.2 Rheumatoid Arthritis (RA) Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 Global Rheumatoid Arthritis (RA) Drugs Market Competition, by Players
3.1 Global Rheumatoid Arthritis (RA) Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Rheumatoid Arthritis (RA) Drugs Players Market Share
3.2.2 Top 10 Rheumatoid Arthritis (RA) Drugs Players Market Share
3.3 Market Competition Trend
4 Global Rheumatoid Arthritis (RA) Drugs Market Size by Regions
4.1 Global Rheumatoid Arthritis (RA) Drugs Revenue and Market Share by Regions
4.2 North America Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
5 North America Rheumatoid Arthritis (RA) Drugs Revenue by Countries
5.1 North America Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018)
5.2 USA Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
6 Europe Rheumatoid Arthritis (RA) Drugs Revenue by Countries
6.1 Europe Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018)
6.2 Germany Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
6.4 France Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Countries
7.1 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018)
7.2 China Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
7.5 India Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
8 South America Rheumatoid Arthritis (RA) Drugs Revenue by Countries
8.1 South America Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018)
8.2 Brazil Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Rheumatoid Arthritis (RA) Drugs by Countries
9.1 Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018)
10 Global Rheumatoid Arthritis (RA) Drugs Market Segment by Type
10.1 Global Rheumatoid Arthritis (RA) Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Rheumatoid Arthritis (RA) Drugs Market Forecast by Type (2018-2023)
10.3 Oral Revenue Growth Rate (2013-2023)
10.4 Injection Revenue Growth Rate (2013-2023)
10.5 External Revenue Growth Rate (2013-2023)
11 Global Rheumatoid Arthritis (RA) Drugs Market Segment by Application
11.1 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Application (2013-2018)
11.2 Rheumatoid Arthritis (RA) Drugs Market Forecast by Application (2018-2023)
11.3 Medical Care Revenue Growth (2013-2018)
11.4 Personal Care Revenue Growth (2013-2018)
12 Global Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2018-2023)
12.1 Global Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2018-2023)
12.2 Global Rheumatoid Arthritis (RA) Drugs Market Forecast by Regions (2018-2023)
12.3 North America Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023)
12.6 South America Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Rheumatoid Arthritis (RA) Drugs Picture
Table Product Specifications of Rheumatoid Arthritis (RA) Drugs
Table Global Rheumatoid Arthritis (RA) Drugs and Revenue (Mil
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
